{"pub": "investing.com", "url": "https://investing.com/analysis/reata-reta-jumps-stock-rises-5-6-200474440", "downloaded_at": "2019-10-17 14:39:29.787051+00:00", "title": "Reata (RETA) Jumps: Stock Rises 5. 6%", "language": "en", "text": "Reata Pharmaceuticals, Inc. (NASDAQ: ) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $74.57 to $157.92 in the past one-month time frame.\n\n\n\nThe company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.\n\n\n\nReata currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.\n\nReata Pharmaceuticals, Inc. Price\n\nInvestors interested in the Medical - Biomedical and Genetics industry may consider AVEO Pharmaceuticals, Inc. (NASDAQ: ) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today\u2019s Zacks #1 Rank stocks here.\n\n\n\nIs RETA going up? Or down? Predict to see what others think: Up or Down\n\n\n\n7 Best Stocks for the Next 30 Days\n\n\n\nJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers \u201cMost Likely for Early Price Pops.\u201d\n\n\n\nSince 1988, the full list has beaten the market more than 2X over with an average gain of +24.50% per year. So be sure to give these hand-picked 7 your immediate attention.\n\n\n\nSee them now >>", "description": "Stocks Analysis by Zacks Investment Research covering: AVEO Pharmaceuticals Inc, Reata Pharmaceuticals Inc. Read Zacks Investment Research's latest article on Investing.com", "authors": [], "top_image": "https://i-invdn-com.akamaized.net/redesign/images/seo/investingcom_analysis_og.jpg", "published_at": "2019-10-17"}